Featuring a short PEG2 chain and Fmoc protection, Fmoc-N-amido-PEG2-propionic acid enhances site-specific conjugation in ADCs. Its design improves solubility and stability, supporting effective therapeutic payload delivery in antibody-drug conjugates.
Structure of 872679-70-4
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01135 | Fmoc-N-amido-PEG4-propionic acid | 557756-85-1 | |
BADC-01153 | Fmoc-N-amido-PEG8-propionic acid | 756526-02-0 | |
BADC-01171 | Fmoc-N-amido-PEG3-propionic acid | 867062-95-1 | |
BADC-01185 | Fmoc-N-amido-PEG6-propionic acid | 882847-34-9 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.